Piper Sandler raised the firm’s price target on Teladoc (TDOC) to $13 from $11 and keeps an Overweight rating on the shares following a Fireside Chat with CEO Chuck Divita and CFO Mala Murthy. The firm believes CY24 chronic care headwinds are transitory and expects Integrated Care segment growth to return to mid-single digits after a transition year in CY25.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC: